Thalia Therapeutics Plc (0GO)
FSX
0.00800
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
0.008000.00800
52 wk Range
0.000500.0265
Financial Statements - 0GO - Thalia Therapeutics Plc
Revenue
7.26K▼ 0.2%
Net Income
-1.20M▼ 7.9%Net Margin -16632.9%
EBITDA
-1.28M▼ 11.0%
Free Cash Flow
-1.16M▼ 19.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 7.26K | 7.28K | 1.95K | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | 7.26K | 7.28K | 1.95K | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.22M | -1.15M | -1.33M | -1.19M | -1.84M | -1.56M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -1.16M | -1.22M | -1.42M | -1.19M | -1.84M | -1.56M |
| Income Tax | 42.99K | -101.11K | -147.81K | -163.99K | -298.26K | -261.54K |
| Net Income | -1.20M | -1.11M | -1.27M | -1.02M | -1.54M | -1.30M |
| EPS Basic | -0.0017 | -0.0031 | -0.0052 | -0.0055 | -0.0085 | -0.0096 |
| EPS Diluted | -0.0017 | -0.0031 | -0.0052 | -0.0055 | -0.0085 | -0.0096 |
| Basic Shares Outstanding | 724.40M | 340.38M | 242.88M | 186.42M | 181.08M | 136.30M |
| Diluted Shares Outstanding | 724.40M | 340.38M | 242.88M | 186.42M | 181.08M | 136.30M |
| Ebit | -1.22M | -1.15M | -1.33M | -1.19M | -1.84M | -1.56M |
| Ebitda | -1.28M | -1.15M | -1.33M | -1.19M | -1.84M | -1.56M |
| Net Income Continuous Operations | -1.20M | -1.11M | -1.27M | -1.02M | -1.54M | -1.30M |
| Minority Interests | 3.12K | 61.36K | 7.44K | 0 | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
